QTL for ethanol withdrawal on Chr1 at D1Mit122 (42.42 Mbp , Build 37)
Description:
ethanol withdrawal spans 17.42 - 67.42 Mbp (NCBI Build 37) on Chr1. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
QTL for METH responses for body temperature on Chr1 at D1Ncvs75 (79.87 Mbp , Build 37)
Description:
METH responses for body temperature spans 54.87 - 104.87 Mbp (NCBI Build 37) on Chr1. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
QTL for chronic alcohol withdrawal severity on Chr1 at D1Mit46 (83.89 Mbp , Build 37)
Description:
chronic alcohol withdrawal severity spans 58.89 - 108.89 Mbp (NCBI Build 37) on Chr1. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
Authors:
Bergeson SE, Kyle Warren R, Crabbe JC, Metten P, Gene Erwin V, Belknap JK
Chronic cocaine - Cocaine vs. Saline DNA microarray increased expression 20 mg / kg / day for 7 days Pair-wise comparisons were made between all 4 conditions (WT Saline, WT Cocaine, KO Saline, KO Cocaine), which generated 4 lists of genes 1.2-fold differentially expressed with a P < 0.05. Genes that were significantly regulated by these criteria in the first duplicate study and validated directly via qPCR were included in the final lists. (NIF Table ID 36 [42])
Authors:
Renthal W, Maze I, Krishnan V, Covington HE 3rd, Xiao G, Kumar A, Russo SJ, Graham A, Tsankova N, Kippin TE, Kerstetter KA, Neve RL, Haggarty SJ, McKinsey TA, Bassel-Duby R, Olson EN, Nestler EJ
QTL associated with B.burgdorferi-associated arthritis 11. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (65896421)
Authors:
Roper RJ, Weis JJ, McCracken BA, Green CB, Ma Y, Weber KS, Fairbairn D, Butterfield RJ, Potter MR, Zachary JF, Doerge RW, Teuscher C
QTL associated with bone response to mechanical loading 8. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (78202934)
QTL associated with cyclophosphamide induced apoptosis. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (66992757)
Authors:
Bergman ML, Cilio CM, Penha-Gonalves C, Lamhamedi-Cherradi SE, Lfgren A, Colucci F, Lejon K, Garchon HJ, Holmberg D
QTL associated with cytokine deficiency colitis susceptibility 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (65899760)
QTL associated with cocaine induced activation 5. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (88315827)
QTL associated with darker modification of yellow agouti QTL 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (45435458)
QTL associated with darker modification of yellow agouti QTL 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (73734337)
QTL associated with "early growth rate, maternal effect 1". This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (74999392)
QTL associated with granulosa cell tumorigenesis 7. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (64357309)
Authors:
Dorward AM, Shultz KL, Horton LG, Li R, Churchill GA, Beamer WG
QTL associated with obesity QTL 7. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (65896421)
Authors:
Brown AC, Olver WI, Donnelly CJ, May ME, Naggert JK, Shaffer DJ, Roopenian DC
Add Selected GeneSets to Project(s)
Warning: You are not signed in. Adding these genesets to a project will create a guest account for you.
Guest accounts are temporary, and will be removed within 24 hours of creation. Guest accounts can be registered as full accounts, but you cannot associate a guest account with an existing account.
If you already have an account, you should sign into that account before proceeding.